Skip to main content

Day: May 25, 2021

Chalice Brands Ltd. Reports Record First Quarter 2021 Revenues of $5.5 million and Consecutive Positive Adjusted EBITDA(1)

Focus on recapitalization, pipeline growth, and optimization of run stage in Oregon PORTLAND, Ore., May 25, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd. (CSE:CHAL) (OTCQB:GLDFF) (“Chalice” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announces its financial and operating results for the first quarter 2021. All amounts stated are in US Dollars unless otherwise noted. Q1 2021 Financial Highlights:Record quarterly revenues from continuing operations of $5.5 million, a 18% year-over-year increase compared to $4.7 million for the same period in 2020. Gross profit for Q1 2021 of $2.5M or 45% gross margin compared to $1.7M or 37% gross margin in 2020. Gross margin improvements are due to increased sales...

Continue reading

Arbor Realty Trust, Inc. Announces Public Offering of Series D Cumulative Redeemable Preferred Stock

UNIONDALE, N.Y., May 25, 2021 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (the “Company”) (NYSE: ABR) announced today that it plans to make a public offering of an initial issuance of its Series D Cumulative Redeemable Preferred Stock (the “Series D Preferred Stock”). In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase additional shares of Series D Preferred Stock to cover over-allotments, if any. The Company intends to file an application to list the Series D Preferred Stock on the NYSE under the symbol “ABR PrD” and, if approved, expects trading to commence within 30 days after the initial issuance of the Series D Preferred Stock.The Company intends to use the net proceeds from the offering to make investments relating to its business and for general corporate purposes,...

Continue reading

Resonant to Host One-On-One Meetings at the 18th Annual Craig-Hallum Institutional Investor Conference on June 2nd

AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, today announced that management will participate in the 18th Annual Craig-Hallum Institutional Investor Conference taking place on Wednesday, June 2, 2021. Resonant management will provide a business update and RF filter industry overview, focusing on how Resonant’s XBAR® RF filter technology is facilitating the transition to next-generation, ultra-fast wireless networks like 5G, Wi-Fi 6E, and Ultra-wideband. Resonant management will host virtual one-on-one meetings throughout the day on Wednesday, June 2nd. Conference participation is by invitation only and registration is mandatory. To schedule a one-on-one...

Continue reading

ME2C® Environmental Announces Court Approval to Proceed with Litigation Claims Against Refined Coal Entities

Response from the U.S District Court in Delaware Allows Litigation Proceedings to Move Forward CORSICANA, TX, May 25, 2021 (GLOBE NEWSWIRE) — Midwest Energy Emissions Corp. (OTCQB: MEEC) (“ME2C Environmental” or the “Company”), a leading environmental technologies firm, announced today that on May 20, 2021, a U.S. District Court Magistrate Judge for the District of Delaware issued a Report and Recommendation that the pending patent litigation commenced in 2019 should be allowed to move forward against 16 key refined coal process defendants named in such lawsuit. “We are extremely pleased with the Court’s recommendation against those entities whom we believe have been infringing on our patented mercury capture technologies since the inception of the refined coal program,” said Richard MacPherson, CEO of ME2C Environmental....

Continue reading

Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2021

Revenues up 11% to $11.5 million; Adjusted EBITDA up 27% to $2.3 million BEVERLY, Mass. and TORONTO, May 25, 2021 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results for the quarter-ended March 31, 2021. HighlightsSales in USD increased 11% year over year to $11.5 million; organic growth up 11% Gross profit increased 13% year over year to $5.9 million Net income increased 495% to $866 thousand Adjusted EBITDA increased 27% year over year to $2.3 million Sales increased 5% in constant currency; organic constant currency growth up 5% Cash flow from operations was $1.5 million for the quarter, up 111%; total cash at March...

Continue reading

Golden Star Enterprises Ltd. Announces Acquisition and Introduces New Corporate Mandate

Claymont, DE, May 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Golden Star Enterprises Ltd. (OTCPink: GSPT) reports it has recently completed a change in management and has shifted its operational focus going forward. Previously, the cornerstone of the operations of Golden Star Enterprises was drone technology.  The current management of GSPT has determined to change its corporate direction, ceasing operations in the drone space and introducing a new corporate mandate. “Our goal for GSPT is to provide an accelerator hub for cutting-edge tech companies,” said Mr. Eliav Kling, Golden Star Enterprises CEO. “We would like to be able to serve as a holding company for a series of operating entities with complementary business models, all under the Golden Star Enterprises umbrella.” To further the Company’s new corporate focus,...

Continue reading

Rain Therapeutics Reports First Quarter 2021 Financial Results and Highlights Recent Progress

Completed initial public offering (“IPO”) with net proceeds of $121.9 million Key appointments to the leadership team, board of directors and scientific advisory board Planned Phase 3 trial initiation in 2H 2021 for RAIN-32 in well-differentiated (“WD”)/de-differentiated (“DD”) liposarcoma Planned initiation of an open-label MDM2-amplified tumor-agnostic Phase 2 basket trial for RAIN-32 in 2H 2021 NEWARK, Calif., May 25, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (“Rain”), a clinical-stage company developing precision oncology therapeutics, today reports financial results for the first quarter that ended March 31, 2021, along with an update on the company’s key developments, business operations and upcoming milestones. “We are thrilled with the progress made so far this year, which...

Continue reading

Nokia launches world’s first AI use case library on public cloud for telecoms providers

Press Release Nokia launches world’s first AI use case library on public cloud for telecoms providersNokia’s AVA AI use case library is now delivered as a service on Microsoft Azure’s public cloud, combining telco grade security and instant web scale architecture scalability. Accelerates communication service providers (CSPs) digital transformation, increases efficiency, reduces energy consumption and improves customer experience. CSPs around the world can now inject AI into their networks nine times faster compared to using private cloud.25th of May 2021 Espoo, Finland – Nokia today announced the world’s first deployment of multiple AI use cases delivered over public cloud, through collaboration with Microsoft. By integrating Nokia’s security framework with Microsoft Azure’s digital architecture, communications service providers...

Continue reading

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease

TORONTO, May 25, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has filed an application with the U.S. Food and Drug Administration (“FDA”) to receive Orphan Drug Designation (“ODD”) for ketamine to treat amyotrophic lateral sclerosis (“ALS”), also known as Lou Gehrig’s disease. ALS is a progressive neuromuscular disease with a life expectancy of only two to six years after diagnosis. Currently, there is no known cure for ALS. ALS affects approximately 50,000 people in the U.S. and Europe, with over 5,000 new cases diagnosed annually. As ALS advances, upper and lower motor neurons die, causing the brain to lose its ability to control muscle movement. ALS patients experience progressive...

Continue reading

Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore

Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures FORT LAUDERDALE, Fla., May 25, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that Sinai Hospital of Baltimore, a LifeBridge Health center, will move ahead with fully adopting the Pure-Vu® System with the aim of improving efficiencies and clinical outcomes of inpatient colonoscopy procedures for patients who present with inadequate bowel preparation. Sinai Hospital, a nonprofit teaching hospital with renowned Centers of Excellence, is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.